Optic neuritis and autoimmune optic neuropathies: advances in diagnosis and treatment.
Bennett JL, Costello F, Chen JJ, Petzold A, Biousse V, Newman NJ, Galetta SL.
Lancet Neurol. 2023 Jan;22(1):89-100. doi: 10.1016/S1474-4422(22)00187-9. Epub 2022 Sep 22.
An update on optic neuritis.
Kraker JA, Chen JJ.
J Neurol. 2023 Oct;270(10):5113-5126. doi: 10.1007/s00415-023-11920-x. Epub 2023 Aug 5.
Treatment and Relapse Prevention of Typical and Atypical Optic Neuritis.
Saitakis G, Chwalisz BK.
Int J Mol Sci. 2022 Aug 29;23(17):9769. doi: 10.3390/ijms23179769.
[Optic neuritis: aetiopathogenesis, diagnosis, prognosis and management].
Rodríguez-Acevedo B, Rovira A, Vidal-Jordana A, Moncho D, Pareto D, Sastre-Garriga J.
Rev Neurol. 2022 Feb 1;74(3):93-104. doi: 10.33588/rn.7403.2021473.
Optic Neuritis.
Guier CP, Kaur K, Stokkermans TJ.
2025 Jan 20. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan–.
Optic neuritis.
Pau D, Al Zubidi N, Yalamanchili S, Plant GT, Lee AG.
Eye (Lond). 2011 Jul;25(7):833-42. doi: 10.1038/eye.2011.81. Epub 2011 Apr 29.
The spectrum of neuromyelitis optica.
Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG.
Lancet Neurol. 2007 Sep;6(9):805-15. doi: 10.1016/S1474-4422(07)70216-8.
Autoantibodies in neurological disease.
Prüss H.
Nat Rev Immunol. 2021 Dec;21(12):798-813. doi: 10.1038/s41577-021-00543-w. Epub 2021 May 11.
Evidence-based management of optic neuritis.
Bergeron E, Bouffard MA.
Curr Opin Ophthalmol. 2024 Jan 1;35(1):73-82. doi: 10.1097/ICU.0000000000001007. Epub 2023 Oct 16.
[Typical and atypical optic neuritis].
Sheremet NL, Eliseeva DD, Kalashnikova AK, Zakharova MN.
Vestn Oftalmol. 2023;139(6):175-182. doi: 10.17116/oftalma2023139061175.
